MIAMI / Sep 11, 2024 / Business Wire / Ontrak, Inc. (NASDAQ: OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, announced that its Chief Innovation Officer, Brianna Brennan, will be a featured speaker at two influential healthcare events on September 25, 2024.
Becker's Healthcare Webinar
Ms. Brennan will present at the Becker's Healthcare Webinar, "Beyond the Numbers: How Holistic Member Journeys Drive Health Plan ROI," at 12:30 PM ET. This virtual event will focus on how health plans can leverage integrated data and holistic approaches to improve member outcomes and reduce costs.
Key topics include:
Healthcare professionals can register for the webinar at Becker's Healthcare registration link.
Women's Health Innovation Summit USA
Later that day, Ms. Brennan will participate in a panel discussion at the Women's Health Innovation Summit USA in Boston, MA. The session, "AI & Behavioral Health: What's the Potential for Women's Health?" is scheduled to begin at 4:30 PM ET.
This discussion will explore the exciting opportunities AI presents in augmenting behavioral health delivery and improving access to care, with a specific focus on women's mental health.
For more information about the Women's Health Innovation Summit, visit the summit's website.
About Ontrak Health
Ontrak Health (Nasdaq: OTRK) is a leading AI and technology-enabled behavioral healthcare company whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder, and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socioeconomic, medical, and health system barriers that exacerbate the severity of their comorbid illnesses. The company's integrated intervention platform uses AI, predictive analytics, and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.
Last Trade: | US$1.44 |
Daily Change: | -0.02 -1.37 |
Daily Volume: | 17,045 |
Market Cap: | US$6.080M |
November 13, 2024 November 06, 2024 September 05, 2024 August 29, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB